Harmony Biosciences Holdings, Inc. - Common Stock (HRMY)
CUSIP: 413197104
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,644,670
- Total 13F shares
- 50,163,988
- Share change
- +1,186,291
- Total reported value
- $1,513,604,428
- Put/Call ratio
- 128%
- Price per share
- $30.17
- Number of holders
- 218
- Value change
- +$34,652,893
- Number of buys
- 106
- Number of sells
- 94
Quarterly Holders Quick Answers
What is CUSIP 413197104?
CUSIP 413197104 identifies HRMY - Harmony Biosciences Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 413197104:
Top shareholders of HRMY - Harmony Biosciences Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Valor Management LLC |
13F
|
Company |
19%
|
11,218,033
|
$376,701,548 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
10%
|
5,922,761
|
$198,886,314 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
9.1%
|
5,255,518
|
$176,480,295 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.3%
|
3,628,225
|
$121,835,796 | — | 31 Mar 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
4.5%
|
2,606,247
|
$87,517,774 | — | 31 Mar 2024 | |
| Pacer Advisors, Inc. |
13F
|
Company |
4.3%
|
2,494,914
|
$83,779,212 | — | 31 Mar 2024 | |
| Andreas Wicki |
3/4/5
|
Director |
—
class O/S missing
|
2,147,943
|
$71,655,378 | — | 12 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
1,295,544
|
$43,504,368 | — | 31 Mar 2024 | |
| venBio Partners LLC |
13F
|
Company |
1.8%
|
1,035,396
|
$34,768,598 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.5%
|
885,345
|
$29,729,901 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.5%
|
844,588
|
$28,361,264 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
753,777
|
$25,315,498 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1%
|
581,620
|
$19,530,800 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.91%
|
525,541
|
$17,647,667 | — | 31 Mar 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.88%
|
508,249
|
$17,067,002 | — | 31 Mar 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.88%
|
506,154
|
$16,996,651 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.77%
|
443,396
|
$14,889,238 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.7%
|
403,369
|
$13,545,131 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.66%
|
380,100
|
$12,764,000 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.65%
|
373,516
|
$12,542,668 | — | 31 Mar 2024 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.64%
|
368,665
|
$12,379,771 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.6%
|
346,226
|
$11,626,269 | — | 31 Mar 2024 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.58%
|
335,146
|
$11,254,000 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.56%
|
323,514
|
$10,863,600 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.52%
|
299,906
|
$10,071,000 | — | 31 Mar 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.51%
|
295,000
|
$9,906,100 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.5%
|
288,647
|
$9,692,766 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.49%
|
281,200
|
$9,442,696 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.48%
|
279,435
|
$9,383,427 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.41%
|
237,327
|
$7,969,441 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.37%
|
210,954
|
$7,083,835 | — | 31 Mar 2024 | |
| CAPITAL MANAGEMENT CORP /VA |
13F
|
Company |
0.36%
|
208,994
|
$7,018,019 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.35%
|
202,729
|
$6,807,640 | — | 31 Mar 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.33%
|
192,050
|
$6,449,039 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.32%
|
185,083
|
$6,214,263 | — | 31 Mar 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.31%
|
177,454
|
$5,958,905 | — | 31 Mar 2024 | |
| Atle Fund Management AB |
13F
|
Company |
0.29%
|
170,000
|
$5,708,600 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.29%
|
165,755
|
$5,566,053 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.28%
|
163,530
|
$5,491,337 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.27%
|
155,510
|
$5,222,026 | — | 31 Mar 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.27%
|
153,229
|
$5,145,430 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.26%
|
152,200
|
$5,110,876 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
0.25%
|
144,559
|
$4,854,291 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.23%
|
133,908
|
$4,496,630 | — | 31 Mar 2024 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.22%
|
127,611
|
$4,285,000 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.22%
|
124,520
|
$4,181,382 | — | 31 Mar 2024 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.21%
|
122,000
|
$4,096,760 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.2%
|
113,477
|
$3,810,558 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.18%
|
104,115
|
$3,496,161 | — | 31 Mar 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.17%
|
98,238
|
$3,298,832 | — | 31 Mar 2024 |
Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q2 2024
As of 30 Jun 2024,
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) was held by
218 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,163,988 shares.
The largest 10 holders included
Valor Management LLC, BlackRock Inc., FMR LLC, VANGUARD GROUP INC, Vivo Capital, LLC, Pacer Advisors, Inc., STATE STREET CORP, venBio Partners LLC, DIMENSIONAL FUND ADVISORS LP, and MORGAN STANLEY.
This page lists
219
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
206
Q2 2024 holders
218
Holder diff
12
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.